Other states looking to spend public money on stem cell research
By Capitol Weekly,
Capitol Weekly
| 01. 19. 2006
During the 2004 elections, supporters of California's Proposition 71 stem
cell effort said they hoped the initiative would serve as an example to
other states. As more than a dozen other states pursue their own stem cell
efforts, it appears California is in fact being used as an example--but in
some cases, it is being held as an example of what not to do.
While critics of California's stem cell agency have focused on what they see
as conflicts of interests and unfulfilled promises, observers in other
states say the far bigger problem is the sheer size and visibility of
California's program.
"A key lesson so far has been that low profile efforts seem more effective,"
said Aaron Levine, a PhD. candidate at Princeton University who has been
studying stem cell campaigns in different states. "Because Proposition 71
dealt with such large sums of money, it became a national, if not
international, issue and attracted significant opposition."
The debate also took place in the shadow of the Bush administration's
efforts to limit the scope of stem cell research, which helped...
Related Articles
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Ed Pilkington, The Guardian | 06.12.2026
Desperate US parents paying up to $20,000 a session for a procedure scientists say could be bogus
Autistic children as young as 18 months old are being injected with human stem cells derived from umbilical cords in unapproved, unproven and...
By Tobi Thomas, The Guardian | 06.10.2026
The UK’s stem cell transplant system is potentially putting the lives of blood cancer patients at risk as a result of inadequate infrastructure and a lack of long-term planning, a parliamentary report has found.
A hematopoietic stem cell transplant, often...